Centre for Inflammatory Diseases, Department of Medicine, School of Clinical Sciences at Monash Health, Monash Medical Centre, Monash University, Clayton, VIC, 3168, Australia.
Baker Heart and Diabetes Institute, Melbourne, Australia.
J Neuroinflammation. 2018 Oct 22;15(1):293. doi: 10.1186/s12974-018-1329-8.
High-fat feeding and hyperglycemia, key risk factors for the development of metabolic syndrome (MetS), are emerging to associate with increased risk of developing dementia and cognitive decline. Despite this, clinical and experimental studies have yet to elucidate the specific contributions of either high-fat feeding or hyperglycemia to potential neuroinflammatory components. In this study, we delineate these individual components of MetS in the development of neuroinflammation.
Male C57Bl/6 J adult mice were treated with either citrate vehicle (CIT) or streptozotocin (STZ; 55 mg/kg) 3, 5 and 7 days before commencement of either a normal or high-fat diet for 9 or 18 weeks. By creating separate models of high-fat feeding, STZ-induced hyperglycemia, as well as in combination, we were able to delineate the specific effects of a high-fat diet and hyperglycemia on the brain. Throughout the feeding regime, we measured the animals' body weight and fasting blood glucose levels. At the experimental endpoint, we assessed plasma levels of insulin, glycated haemoglobin and performed glucose tolerance testing. In addition, we examined the effect of high fat-feeding and hyperglycemia on the levels of systemic inflammatory cytokines, gliosis in the hippocampus and immune infiltration in cerebral hemispheric tissue. Furthermore, we used intravital multiphoton microscopy to assess leukocyte-endothelial cell interactions in the cerebral vasculature of mice in vivo.
We showed that acute hyperglycemia induces regional-specific effects on the brain by elevating microglial numbers and promotes astrocytosis in the hippocampus. In addition, we demonstrated that chronic hyperglycemia supported the recruitment of peripheral GR1 granulocytes to the cerebral microvasculature in vivo. Moreover, we provided evidence that these changes were independent of the systemic inflammation associated with high-fat feeding.
Hyperglycemia alone preferentially induces microglial numbers and astrocytosis in the hippocampus and is associated with the peripheral recruitment of leukocytes to the cerebrovasculature, but not systemic inflammation. High-fat feeding alone, and in combination with hyperglycemia, increases the systemic pro-inflammatory cytokine milieu but does not result in brain-specific immune gliosis. These results shed light on the specific contributions of high-fat feeding and hyperglycemia as key factors of MetS in the development of neuroinflammation.
高脂肪喂养和高血糖是代谢综合征(MetS)发展的关键风险因素,现已发现它们与痴呆和认知能力下降的风险增加有关。尽管如此,临床和实验研究尚未阐明高脂肪喂养或高血糖对潜在神经炎症成分的具体贡献。在这项研究中,我们阐述了 MetS 的这些组成部分在神经炎症发展中的作用。
雄性 C57Bl/6J 成年小鼠在开始正常或高脂肪饮食前 3、5 和 7 天,用柠檬酸载体(CIT)或链脲佐菌素(STZ;55mg/kg)处理,共 9 或 18 周。通过分别建立高脂肪喂养、STZ 诱导的高血糖以及两者结合的模型,我们能够阐明高脂肪饮食和高血糖对大脑的具体影响。在整个喂养过程中,我们测量动物的体重和空腹血糖水平。在实验终点,我们检测了血浆胰岛素、糖化血红蛋白水平,并进行了葡萄糖耐量测试。此外,我们还研究了高脂肪喂养和高血糖对全身炎症细胞因子水平、海马神经胶质增生和大脑半球组织免疫浸润的影响。此外,我们使用活体多光子显微镜评估了白细胞-内皮细胞在体内小鼠脑血管中的相互作用。
我们发现急性高血糖通过增加小胶质细胞数量对大脑产生区域特异性影响,并促进海马区的星形胶质细胞增生。此外,我们证明了慢性高血糖支持外周 GR1 粒细胞在体内向大脑微血管的募集。此外,我们提供的证据表明,这些变化与高脂肪喂养相关的系统性炎症无关。
单独的高血糖优先诱导海马区小胶质细胞数量和星形胶质细胞增生,并与白细胞向脑血管的外周募集有关,但与系统性炎症无关。单独的高脂肪喂养以及与高血糖联合作用,会增加全身促炎细胞因子环境,但不会导致大脑特异性免疫神经胶质增生。这些结果阐明了高脂肪喂养和高血糖作为 MetS 发展中神经炎症的关键因素的具体贡献。